Disturbed follicular architecture in B cell a disintegrin and metalloproteinase (ADAM)10 knockouts is mediated by compensatory increases in ADAM17 and TNF-α shedding

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 5951-5958

  Folgosa, Lauren ^a   Zellner, Hannah B ^a   Shikh, Mohey Eldin ^b   Conrad, Daniel H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL COMPARTMENTALIZATION; CELL LOSS; CELL MATURATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME RECONSTITUTION; FEMALE; FOLLICULAR DENDRITIC CELL; GENE SILENCING; LYMPHOID TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN SECRETION; RNA STABILITY; SIGNAL TRANSDUCTION; TISSUE STRUCTURE; UPREGULATION;

EID: 84890403593     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302042     Document Type: Article

References (36)

1. Edwards, D. R., M. M. Handsley, and C. J. Pennington. 2008. The ADAM metalloproteinases. Mol. Aspects Med. 29: 258-289.
2. Le Gall, S. M., P. Bobé, K. Reiss, K. Horiuchi, X. D. Niu, D. Lundell, D. R. Gibb, D. Conrad, P. Saftig, and C. P. Blobel. 2009. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Mol. Biol. Cell 20: 1785-1794.
3. Mezyk-Kopeć, R., M. Bzowska, K. Stalińska, T. Chełmicki, M. Podkalicki,J. Jucha, K. Kowalczyk, P. Mak, and J. Bereta. 2009. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts. Cytokine 46: 309-315.
4. Gibb, D. R., M. El Shikh, D. J. Kang, W. J. Rowe, R. El Sayed, J. Cichy, H. Yagita, J. G. Tew, P. J. Dempsey, H. C. Crawford, and D. H. Conrad. 2010. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. J. Exp. Med. 207: 623-635.
5. Weskamp, G., J. W. Ford, J. Sturgill, S. Martin, A. J. Docherty, S. Swendeman, N. Broadway, D. Hartmann, P. Saftig, S. Umland, et al. 2006. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat. Immunol. 7: 1293-1298.
6. Chaimowitz, N. S., R. K. Martin, J. Cichy, D. R. Gibb, P. Patil, D. J. Kang, J. Farnsworth, E. C. Butcher, B. McCright, and D. H. Conrad. 2011. A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture. J. Immunol. 187: 5114-5122.
7. MacEwan, D. J. 2002. TNF ligands and receptors - a matter of life and death. Br. J. Pharmacol. 135: 855-875.
8. Frasca, D., A. M. Landin, J. P. Alvarez, P. J. Blackshear, R. L. Riley, and B. B. Blomberg. 2007. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J. Immunol. 179: 918-927.
9. Lai, W. S., J. S. Parker, S. F. Grissom, D. J. Stumpo, and P. J. Blackshear. 2006. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol. Cell. Biol. 26: 9196-9208.
10. Phillips, K., N. Kedersha, L. Shen, P. J. Blackshear, and P. Anderson. 2004. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc. Natl. Acad. Sci. USA 101: 2011-2016.
11. Taylor, G. A., E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes, and P. J. Blackshear. 1996. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4: 445-454.
12. Frasca, D., M. Romero, A. Diaz, S. Alter-Wolf, M. Ratliff, A. M. Landin, R. L. Riley, and B. B. Blomberg. 2012. A molecular mechanism for TNF-α-mediated downregulation of B cell responses. J. Immunol. 188: 279-286.
13. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184: 1397-1411.
14. Tumanov, A. V., S. I. Grivennikov, A. A. Kruglov, Y. V. Shebzukhov, E. P. Koroleva, Y. Piao, C. Y. Cui, D. V. Kuprash, and S. A. Nedospasov. 2010. Cellular source and molecular form of TNF specify its distinct functions in organization of secondary lymphoid organs. Blood 116: 3456-3464.
15. Dussault, A. A., and M. Pouliot. 2006. Rapid and simple comparison of messenger RNA levels using real-time PCR. Biol. Proced. Online 8: 1-10.
16. Gommerman, J., and O. Rojas. 2011. Creation of mixed bone marrow chimeras with appropriate controls. Protocol Exchange. DOI: 10.1038/protex.2011.269.
17. Vandenbroucke, R. E., E. Dejonckheere, F. Van Hauwermeiren, S. Lodens, R. De Rycke, E. Van Wonterghem, A. Staes, K. Gevaert, C. López-Otin, and C. Libert. 2013. Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF. EMBO Mol. Med. 5: 932-948.
18. Bar-Or, A., R. K. Nuttall, M. Duddy, A. Alter, H. J. Kim, I. Ifergan, C. J. Pennington, P. Bourgoin, D. R. Edwards, and V. W. Yong. 2003. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126: 2738-2749.
19. Aggarwal, B. B., S. C. Gupta, and J. H. Kim. 2012. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 119: 651-665.
20. Thacker, T. C., X. Zhou, J. D. Estes, Y. Jiang, B. F. Keele, T. S. Elton, and G. F. Burton. 2009. Follicular dendritic cells and human immunodeficiency virus type 1 transcription in CD4+ T cells. J. Virol. 83: 150-158.
21. McCall, J. L., K. Yun, S. Funamoto, and B. R. Parry. 1989. In vivo immunohistochemical identification of tumor necrosis factor/cachectin in human lymphoid tissue. Am. J. Pathol. 135: 421-425.
22. Anolik, J. H., R. Ravikumar, J. Barnard, T. Owen, A. Almudevar, E. C. Milner, C. H. Miller, P. O. Dutcher, J. A. Hadley, and I. Sanz. 2008. Cutting edge: antitumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J. Immunol. 180: 688-692.
23. Cordingley, F. T., A. Bianchi, A. V. Hoffbrand, J. E. Reittie, H. E. Heslop, A. Vyakarnam, M. Turner, A. Meager, and M. K. Brenner. 1988. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 1: 969-971.
24. Bauvois, B., J. Dumont, C. Mathiot, and J. P. Kolb. 2002. Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons. Leukemia 16: 791-798.
25. Allen, C. D., and J. G. Cyster. 2008. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin. Immunol. 20: 14-25.
26. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264: 703-707.
27. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon, and D. D. Chaplin. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 271: 1289-1291.
28. Kuprash, D. V., Z. Qin, D. Ito, S. I. Grivennikov, K. Abe, L. N. Drutskaya, T. Blankenstein, and S. A. Nedospasov. 2008. Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice. Cancer Lett. 268: 70-75.
29. Koni, P. A., R. Sacca, P. Lawton, J. L. Browning, N. H. Ruddle, and R. A. Flavell. 1997. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 6: 491-500.
30. Fu, Y. X., and D. D. Chaplin. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17: 399-433.
31. Wang, Y., J. Wang, Y. Sun, Q. Wu, and Y. X. Fu. 2001. Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells. J. Immunol. 166: 330-337.
32. Pasparakis, M., L. Alexopoulou, M. Grell, K. Pfizenmaier, H. Bluethmann, and G. Kollias. 1997. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl. Acad. Sci. USA 94: 6319-6323.
33. Girard, J. P., and T. A. Springer. 1995. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol. Today 16: 449-457.
34. Weskamp, G., K. Mendelson, S. Swendeman, S. Le Gall, Y. Ma, S. Lyman, A. Hinoki, S. Eguchi, V. Guaiquil, K. Horiuchi, and C. P. Blobel. 2010. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ. Res. 106: 932-940.
35. Bajénoff, M., and R. N. Germain. 2009. B-cell follicle development remodels the conduit system and allows soluble antigen delivery to follicular dendritic cells. Blood 114: 4989-4997.
36. Kavian, N., A. Servettaz, B. Weill, and F. Batteux. 2012. New insights into the mechanism of notch signalling in fibrosis. Open. Rheumatol. J. 6: 96-102.